Analysis of tumor recurrence factors of the patients with intermediate risk papillary thyroid carcinoma after radioactive iodine treatment
Journal Title: Journal of Surgery : Concepts & Practice - Year 2023, Vol 28, Issue 6
Abstract
[Objective] To analyze the recurrence factors of the patients with intermediate risk papillary thyroid carcinoma (PTC) after radioactive iodine treatment (RAIT). [Methods] A total of 254 intermediate risk PTC patients after RAIT from January 2018 to May 2020 in our hospital were enrolled into this study. Chi square test and multivariate analysis were applied to analyze the main recurrence factors after RAIT. [Results] Thirty four (13.4%) patients with intermediate risk PTC relapsed after RAIT. The primary tumor size, lymph node metastasis staging, and pre-ablation stimulated thyroglobulin (psTg) were associated with tumor recurrence. According to the receiver operating characteristic （ROC） curve, psTg 25.6 μg/L was the best cutoff value for predicting recurrence. Further multivariate analysis revealed that lymph node metastasis staging and psTg levels were independent factors of predicting PTC recurrence. When the patients with N1b and psTg≥25.6 μg/L, the incidence of tumor recurrence after RAIT was 58.3%. While the patients with N1a and psTg<25.6 μg/L, the incidengce of tumor recurrence was only 2.3%. [Conclusions] Lymph node metastasis staging and psTg level are the important indicators of PTC recurrence, and combining these two indicators can help predict tumor recurrence after RAIT.
Authors and Affiliations
Linglin TANG, Li LI, Yi LAI, Jianjun LIU, Xiang ZHOU
Keywords
Related Articles
- EP ID EP750927
- DOI 10.16139/j.1007-9610.2023.06.09
- Views 12
- Downloads 0
Prognostic analysis of the patients with HER2-positive breast cancer adjuvant treated with trastuzumab: a report of 1 246 cases
[Objective] To analyze the prognostic factors in the patients with HER2-positive breast cancer adjuvant treated with trastuzumab. [Methods] We conducted a retrospective analysis of clinical data of 1 246 patients diagnos...
Value of contrast-enhanced ultrasound in differentiating benign and malignant gallbladder lesions which diameter more than 1 cm
[Objective] To investigate the clinical value of contrast-enhanced ultrasound (CEUS) in differential diagnosis between benign and malignant gallbladder lesions which diameter more than 1 cm. [Methods] A retrospective a...
The role of ERCP in the diagnosis and treatment of chronic pancreatitis
Chronic pancreatitis (CP) is a chronic progressive disease that causes varying degrees of functional damage on pancreatic endocrine and exocrine, seriously affecting the quality of life of the patients. Endoscopic retrog...
Endoscopic treatment of gallbladder diseases
In recent years, with the rapid development of digestive endoscopy technology, new endoscopic diagnosis and treatment techniques and methods for gallbladder diseases have emerged, showing unique advantages, vitality and...
Advantages and advances in neoadjuvant therapy of pancreatic cancer
Due to the characteristics of the insidious onset, difficult early diagnosis and high malignancy of pancrea-tic cancer, only a minority of patients still have the chance of surgical resection at the time of diagnosis. In...